• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依维莫司对大鼠局灶性脑缺血再灌注损伤的神经保护作用。

Neuroprotection of Everolimus Against Focal Cerebral Ischemia-Reperfusion Injury in Rats.

机构信息

Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Neuroscience, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran.

出版信息

J Stroke Cerebrovasc Dis. 2022 Aug;31(8):106576. doi: 10.1016/j.jstrokecerebrovasdis.2022.106576. Epub 2022 May 25.

DOI:10.1016/j.jstrokecerebrovasdis.2022.106576
PMID:35633587
Abstract

BACKGROUND

Mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates cell growth and metabolism and integrates various signals under physiological and pathological conditions. Altered signaling of mTOR has been shown to play pathogenic roles in ischemic stroke. In the present study, the protective effect of everolimus, the selective mTOR inhibitor, in the middle cerebral artery occlusion (MCAO) model of ischemic stroke was evaluated.

METHODS

Wistar rats were exposed to MCAO (30 min) followed by reperfusion for 24 h. Everolimus (100, and 500 µg/kg) was administered at the time of reperfusion, intraperitoneally. 24 h post operation, the neurological function, infarct volume, histopathological alterations and the markers of oxidative stress including superoxide dismutase (SOD) activity, malondialdehyde (MDA), and total thiol levels were analyzed in the peri-infarct region.

RESULTS

In the rats subjected to MCAO, everolimus ameliorated neurological deficits, neuronal cell loss, and infarct volume, as compared to the stroke group. Also, everolimus significantly increased SOD activity and total thiol content, while markedly decreased the MDA level, as compared to MCAO group.

CONCLUSION

Single-dose administration of everolimus significantly improved neurological deficits and inhibited cortical cell loss by enhancing redox status, subsequently protected cerebral ischemia-reperfusion injury in rats.

摘要

背景

雷帕霉素靶蛋白(mTOR)是一种丝氨酸/苏氨酸激酶,可调节细胞生长和代谢,并在生理和病理条件下整合各种信号。已经表明,mTOR 信号的改变在缺血性中风中起致病作用。在本研究中,评估了雷帕霉素(mTOR 的选择性抑制剂)在大脑中动脉闭塞(MCAO)缺血性中风模型中的保护作用。

方法

Wistar 大鼠暴露于 MCAO(30 分钟)后再灌注 24 小时。雷帕霉素(100 和 500μg/kg)在再灌注时腹腔内给药。手术后 24 小时,在梗塞周围区域分析神经功能、梗塞体积、组织病理学改变以及氧化应激标志物,包括超氧化物歧化酶(SOD)活性、丙二醛(MDA)和总巯基水平。

结果

与中风组相比,MCAO 大鼠中雷帕霉素改善了神经功能缺损、神经元细胞丢失和梗塞体积。与 MCAO 组相比,雷帕霉素还显著增加了 SOD 活性和总巯基含量,同时明显降低了 MDA 水平。

结论

单次给予雷帕霉素可通过增强氧化还原状态显著改善神经功能缺损并抑制皮质细胞丢失,从而保护大鼠脑缺血再灌注损伤。

相似文献

1
Neuroprotection of Everolimus Against Focal Cerebral Ischemia-Reperfusion Injury in Rats.依维莫司对大鼠局灶性脑缺血再灌注损伤的神经保护作用。
J Stroke Cerebrovasc Dis. 2022 Aug;31(8):106576. doi: 10.1016/j.jstrokecerebrovasdis.2022.106576. Epub 2022 May 25.
2
Huang-Lian-Jie-Du-Decotion induced protective autophagy against the injury of cerebral ischemia/reperfusion via MAPK-mTOR signaling pathway.黄连解毒汤通过 MAPK-mTOR 信号通路诱导脑缺血/再灌注损伤的保护性自噬。
J Ethnopharmacol. 2013 Aug 26;149(1):270-80. doi: 10.1016/j.jep.2013.06.035. Epub 2013 Jun 28.
3
Mailuoning oral liquid attenuates convalescent cerebral ischemia by inhibiting AMPK/mTOR-associated apoptosis and promoting CREB/BDNF-mediated neuroprotection.脉络宁口服液通过抑制 AMPK/mTOR 相关凋亡和促进 CREB/BDNF 介导的神经保护作用减轻恢复期脑缺血。
J Ethnopharmacol. 2023 Dec 5;317:116731. doi: 10.1016/j.jep.2023.116731. Epub 2023 Jun 3.
4
Total Saponins of Panax notoginseng Activate Akt/mTOR Pathway and Exhibit Neuroprotection in vitro and in vivo against Ischemic Damage.三七总皂苷激活Akt/mTOR信号通路并在体内外对缺血性损伤发挥神经保护作用。
Chin J Integr Med. 2022 May;28(5):410-418. doi: 10.1007/s11655-021-3454-y. Epub 2021 Sep 28.
5
Neuroprotective effect of vildagliptin against cerebral ischemia in rats.维格列汀对大鼠脑缺血的神经保护作用。
Naunyn Schmiedebergs Arch Pharmacol. 2018 Oct;391(10):1133-1145. doi: 10.1007/s00210-018-1537-x. Epub 2018 Jul 18.
6
Neuroprotective effect of herniarin following transient focal cerebral ischemia in rats.胡芦巴素对大鼠短暂性局灶性脑缺血的神经保护作用。
Metab Brain Dis. 2021 Dec;36(8):2505-2510. doi: 10.1007/s11011-021-00841-1. Epub 2021 Sep 14.
7
Neuroprotection by nicotinamide mononucleotide adenylyltransferase 1 with involvement of autophagy in an aged rat model of transient cerebral ischemia and reperfusion.烟酰胺单核苷酸腺苷转移酶 1 通过自噬对短暂性脑缺血再灌注老龄大鼠模型的神经保护作用。
Brain Res. 2019 Nov 15;1723:146391. doi: 10.1016/j.brainres.2019.146391. Epub 2019 Aug 14.
8
The Neuroprotective Effects and Probable Mechanisms of Everolimus in a Rat Model of Intracerebral Hemorrhage.依维莫司对脑出血大鼠模型的神经保护作用及可能机制。
Cell Mol Neurobiol. 2023 Nov;43(8):4219-4230. doi: 10.1007/s10571-023-01409-6. Epub 2023 Sep 25.
9
Arjunolic acid, a pentacyclic triterpenoidal saponin of Terminalia arjuna bark protects neurons from oxidative stress associated damage in focal cerebral ischemia and reperfusion.阿朱诺酸是诃子树皮中的一种五环三萜皂苷,可保护神经元免受局灶性脑缺血再灌注中氧化应激相关的损伤。
Pharmacol Rep. 2015 Oct;67(5):890-5. doi: 10.1016/j.pharep.2015.02.003. Epub 2015 Feb 19.
10
[Experimental study of therapeutic time window of L-serine against focal cerebral ischemia/reperfusion injury in rats].[L-丝氨酸对大鼠局灶性脑缺血/再灌注损伤治疗时间窗的实验研究]
Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2010 Feb;26(1):72-6.

引用本文的文献

1
Experimental and clinical tests of FDA-approved kinase inhibitors for the treatment of neurological disorders (update 2024).美国食品药品监督管理局(FDA)批准的用于治疗神经疾病的激酶抑制剂的实验和临床测试(2024年更新)
Explor Drug Sci. 2025;3. doi: 10.37349/eds.2025.1008116. Epub 2025 Jul 1.
2
Advances in brain remodeling, stem cell therapies, and translational barriers in stroke and brain aging.脑重塑、干细胞疗法的进展以及中风和脑衰老中的转化障碍。
Biogerontology. 2025 Jul 11;26(4):143. doi: 10.1007/s10522-025-10282-3.
3
Amorfrutin A ameliorates cerebral ischemia/reperfsion injury and modulating Nrf2/HO-1 signaling pathway.
阿莫弗鲁汀A可改善脑缺血/再灌注损伤并调节Nrf2/HO-1信号通路。
Korean J Physiol Pharmacol. 2025 Sep 1;29(5):547-557. doi: 10.4196/kjpp.24.304. Epub 2025 May 15.
4
The Neuroprotective Effects and Probable Mechanisms of Everolimus in a Rat Model of Intracerebral Hemorrhage.依维莫司对脑出血大鼠模型的神经保护作用及可能机制。
Cell Mol Neurobiol. 2023 Nov;43(8):4219-4230. doi: 10.1007/s10571-023-01409-6. Epub 2023 Sep 25.
5
FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders.美国食品药品监督管理局批准的用于神经系统疾病临床前和临床试验的激酶抑制剂
Pharmaceuticals (Basel). 2022 Dec 13;15(12):1546. doi: 10.3390/ph15121546.